Last update: Nov. 11, 2020
Moderately safe. Probably compatible.
Mild risk possible. Follow up recommended.
Read the Comment.
Intra-lumen amebicide drug that is used alone or in combination with Metronidazole.
Oral administration 3 times a day for 10 days.
Since the last update we have not found any published data on its excretion in breast milk.
The paucity of available pharmacokinetic data (Drug 2020, CECMED 2015) does not allow predicting the amount of its possible excretion in human milk.
A mild side effect like flatulence observed among treated patients does not represent any risk for the child. No untoward effect on infants has been reported.
It may be given to children from the age of 1 month (BNF 2019 p325).
It is considered an essential medicine by the WHO (WHO 2002).
We do not have alternatives for Διλοξανίδη Φουροϊκή.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.